FOXO TECHNOLOGIES INC.’S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES
FOXO Technologies (NYSE American: FOXO) announced significant operational achievements for its behavioral health subsidiary, Myrtle Recovery Centers. Since launching in Oneida, Tennessee in August 2023, the facility has:
- Treated over 400 patients
- Provided 5,000+ care days
- Projects 10,000 patient care days by end of 2025
Myrtle's CEO Robert Merritt highlighted the facility's strong reputation in East Tennessee for substance use disorder treatment. FOXO's CEO Seamus Lagan expressed satisfaction with the investment and indicated plans for expansion to additional locations to increase revenue contribution.
FOXO Technologies (NYSE American: FOXO) ha annunciato importanti risultati operativi per la sua controllata nel settore della salute comportamentale, Myrtle Recovery Centers. Dall'apertura a Oneida, Tennessee, nell'agosto 2023, la struttura ha:
- Trattato oltre 400 pazienti
- Offerto più di 5.000 giorni di cura
- Prevede di raggiungere 10.000 giorni di cura entro la fine del 2025
Il CEO di Myrtle, Robert Merritt, ha sottolineato la solida reputazione della struttura nell'Est del Tennessee per il trattamento dei disturbi da uso di sostanze. Il CEO di FOXO, Seamus Lagan, si è detto soddisfatto dell'investimento e ha indicato l'intenzione di espandersi in ulteriori sedi per aumentare i ricavi.
FOXO Technologies (NYSE American: FOXO) anunció logros operativos significativos para su subsidiaria de salud conductual, Myrtle Recovery Centers. Desde su apertura en Oneida, Tennessee en agosto de 2023, la instalación ha:
- Atendido a más de 400 pacientes
- Proporcionado más de 5,000 días de atención
- Proyecta 10,000 días de atención para finales de 2025
El CEO de Myrtle, Robert Merritt, destacó la sólida reputación del centro en el este de Tennessee para el tratamiento de trastornos por uso de sustancias. El CEO de FOXO, Seamus Lagan, expresó satisfacción con la inversión y señaló planes de expansión a más ubicaciones para aumentar los ingresos.
FOXO Technologies (NYSE American: FOXO)는 행동 건강 자회사인 Myrtle Recovery Centers의 중요한 운영 성과를 발표했습니다. 2023년 8월 테네시주 오나이다에서 개소한 이 시설은:
- 400명 이상의 환자 치료
- 5,000일 이상의 치료 기간 제공
- 2025년 말까지 10,000일의 환자 치료 기간 달성 예상
Myrtle의 CEO 로버트 메릿은 이 시설이 테네시 동부에서 약물 사용 장애 치료에 있어 강한 명성을 가지고 있다고 강조했습니다. FOXO의 CEO 시머스 라간은 투자에 만족감을 표하며 수익 증대를 위해 추가 지점 확장 계획을 밝혔습니다.
FOXO Technologies (NYSE American : FOXO) a annoncé des réalisations opérationnelles importantes pour sa filiale en santé comportementale, Myrtle Recovery Centers. Depuis son lancement à Oneida, Tennessee en août 2023, l'établissement a :
- Traité plus de 400 patients
- Fournit plus de 5 000 jours de soins
- Prévoit 10 000 jours de soins d'ici fin 2025
Le PDG de Myrtle, Robert Merritt, a souligné la solide réputation de l'établissement dans l'est du Tennessee pour le traitement des troubles liés à l'usage de substances. Le PDG de FOXO, Seamus Lagan, s'est déclaré satisfait de l'investissement et a indiqué des projets d'expansion vers d'autres sites afin d'augmenter les revenus.
FOXO Technologies (NYSE American: FOXO) gab bedeutende operative Erfolge seiner Tochtergesellschaft im Bereich Verhaltensgesundheit, Myrtle Recovery Centers, bekannt. Seit der Eröffnung in Oneida, Tennessee im August 2023 hat die Einrichtung:
- Über 400 Patienten behandelt
- Mehr als 5.000 Betreuungstage bereitgestellt
- Bis Ende 2025 10.000 Betreuungstage prognostiziert
Der CEO von Myrtle, Robert Merritt, hob den guten Ruf der Einrichtung in Ost-Tennessee für die Behandlung von Substanzgebrauchsstörungen hervor. FOXO-CEO Seamus Lagan zeigte sich zufrieden mit der Investition und kündigte Expansionspläne zu weiteren Standorten an, um den Umsatz zu steigern.
- Treated over 400 patients and provided 5,000+ care days since August 2023
- Projecting growth to 10,000 patient care days by end of 2025
- Plans for expansion to additional locations to increase revenue
- Strong presence and reputation in East Tennessee market
- Increasing referral sources indicating business growth
- None.
WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has reached key patient care milestones. Since operations commenced at its Oneida, Tennessee location in August 2023, the facility has seen over 400 patients and has served patients for over 5,000 care days.
Robert Merritt, Chief of Executive Officer of Myrtle stated, “We are excited about reaching these important patient care milestones as they are indicative of the strong presence and reputation our facility has for delivering exemplary care for substance use disorder patients in East Tennessee. We continue to increase our referral sources and believe we will have served 10,000 patient care days by year end 2025 since inception. We look forward to providing care for more residents in the area and are looking to expand our footprint to facilitate an increasing demand for our services.” Seamus Lagan, Chief Executive Officer of parent company, FOXO Technologies Inc., further added, “we are pleased with our investment in Myrtle and how it has ramped up operations and made a significant impact in the rural communities Myrtle serves. We look forward to expanding Myrtle into additional locations and increasing the revenues this subsidiary contributes to FOXO.”
About FOXO Technologies Inc. (“FOXO”)
FOXO owns and operates three subsidiaries.
Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical), a critical access designated (CAH) hospital in East Tennessee.
Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.
FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.
For more information about FOXO, visit www.foxotechnologies.com.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact:
Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151
